Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

Irene Pastor‐Galán; Juan Carlos Hernández‐Boluda; Juan Gonzalo Correa; Alberto Álvarez‐Larrán; Francisca Ferrer‐Marín; José María Raya; Rosa Ayala; Patricia Vélez; Manuel Pérez‐Encinas; Natàlia Estrada; Valentín García‐Gutiérrez; María Laura Fox; Ángel Ramírez Páyer; Ana Kerguelen; Beatriz Cuevas; María Antonia Durán; Marı́a José Ramı́rez; María Teresa Gómez‐Casares; María Isabel Mata‐Vázquez; Elvira Mora; Clara Martínez‐Valverde; Elisa Arbelo; Anna Angona; Elena Magro; María Luisa Antelo; Nieves Somolinos; Francisco Cervantes

doi:10.1016/j.medcle.2019.11.010

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

Irene Pastor‐Galán, Juan Carlos Hernández‐Boluda, Juan Gonzalo Correa, Alberto Álvarez‐Larrán, Francisca Ferrer‐Marín, José María Raya, Rosa Ayala, Patricia Vélez, Manuel Pérez‐Encinas, Natàlia Estrada, Valentín García‐Gutiérrez, María Laura Fox, Ángel Ramírez Páyer, Ana Kerguelen, Beatriz Cuevas, María Antonia Durán, Marı́a José Ramı́rez, María Teresa Gómez‐Casares, María Isabel Mata‐Vázquez, Elvira Mora, Clara Martínez‐Valverde, Elisa Arbelo, Anna Angona, Elena Magro, María Luisa Antelo, Nieves Somolinos, Francisco Cervantes

In: Medicina Clínica (English Edition) · 2020 · vol. 155(4) , pp. 152–158 · doi:10.1016/j.medcle.2019.11.010 · PMID:31980217 · W3001840506

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study analyzed the clinico-biological characteristics of 1,000 myelofibrosis patients from the Spanish Registry of Myelofibrosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results 2015

References (27)

Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results via openalex
doi:10.1056/nejmoa1110557 via openalex
doi:10.1002/ajh.23690 via openalex
doi:10.1038/leu.2010.234 via openalex
doi:10.1200/jco.2012.42.0240 via openalex
doi:10.1182/blood-2014-07-575373 via openalex
doi:10.1182/blood-2010-06-293415 via openalex
doi:10.3324/haematol.2013.101733 via openalex
doi:10.1016/j.mayocp.2011.11.001 via openalex
doi:10.1038/leu.2015.233 via openalex
doi:10.1182/blood-2014-05-579136 via openalex
doi:10.1038/leu.2013.119 via openalex
doi:10.1038/bmt.2016.258 via openalex
doi:10.1111/ejh.12846 via openalex
doi:10.1182/blood-2008-07-170449 via openalex
doi:10.1200/jco.2004.00.9316 via openalex
doi:10.1200/jco.2009.22.8833 via openalex
doi:10.1038/leu.2017.169 via openalex
doi:10.1016/j.leukres.2017.06.001 via openalex
doi:10.1200/jco.2017.76.4886 via openalex
doi:10.3109/10428194.2015.1046866 via openalex
doi:10.3324/haematol.2014.113845 via openalex
doi:10.1182/blood-2009-08-238956 via openalex
doi:10.1038/leu.2017.297 via openalex
doi:10.1182/asheducation-2016.1.543 via openalex
doi:10.1056/nejmoa1110556 via openalex
doi:10.1200/jco.2012.42.1925 via openalex

Source provenance

openalex: last seen: 2026-05-10T10:50:34.479354+00:00
unpaywall: last seen: 2026-06-13T06:42:57.164913+00:00

License: CC0 · commercial use OK

[1] Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results 2015